Non-operative management of patients with rectal cancer: lessons learnt from the OPRA trial

P Goffredo, FF Quezada-Diaz, J Garcia-Aguilar… - Cancers, 2022 - mdpi.com
Simple Summary The management of rectal cancer has become increasingly more complex.
Over the recent year, the use of chemotherapy and radiation before surgical intervention has …

Does neoadjuvant therapy increase the incidence of anastomotic leakage after anterior resection for mid and low rectal cancer? A systematic review and meta …

MH Hu, RK Huang, RS Zhao, KL Yang… - Colorectal …, 2017 - Wiley Online Library
Aim The aim was to evaluate the association of neoadjuvant therapy with increases in the
incidence of anastomotic leakage (AL) after middle and low rectal anterior resection. Method …

Radiation therapy for rectal cancer: executive summary of an ASTRO clinical practice guideline

JY Wo, CJ Anker, JB Ashman, NA Bhadkamkar… - Practical radiation …, 2021 - Elsevier
Purpose This guideline reviews the evidence and provides recommendations for the
indications and appropriate technique and dose of neoadjuvant radiation therapy (RT) in the …

[HTML][HTML] Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled …

JH Song, JU Jeong, JH Lee, SH Kim… - Radiation oncology …, 2017 - ncbi.nlm.nih.gov
Purpose Whether preoperative chemoradiotherapy (CRT) is better than postoperative CRT
in oncologic outcome and toxicity is contentious in prospective randomized clinical trials. We …

Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician …

A Gilbert, L Ziegler, M Martland, S Davidson… - International Journal of …, 2015 - Elsevier
The use of multimodal treatments for rectal cancer has improved cancer-related outcomes
but makes monitoring toxicity challenging. Optimizing future radiation therapy regimens …

Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy

SE Park, IG Hwang, CH Choi, H Kang, BG Kim… - Medicine, 2018 - journals.lww.com
Sarcopenia is associated with low muscle mass and low physical performance. Here, we
performed to evaluate the sarcopenia as prognostic factor and treatment outcomes in older …

A bibliometric analysis of 23,492 publications on rectal cancer by machine learning: basic medical research is needed

K Wang, C Feng, M Li, Q Pei, Y Li… - Therapeutic …, 2020 - journals.sagepub.com
Background and Aims: The aim of this study was to analyse the landscape of publications on
rectal cancer (RC) over the past 25 years by machine learning and semantic analysis …

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer

HK Sanoff, DH Moon, DT Moore, J Boles, C Bui… - … , Biology and Medicine, 2019 - Elsevier
CRLX101 is a nanoparticle-drug conjugate with a camptothecin payload. We assessed the
toxicity and pathologic complete response (pCR) rate of CRLX101 with standard …

Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta‐Analysis

J Yang, Y Luo, T Tian, P Dong, Z Fu - Journal of Oncology, 2022 - Wiley Online Library
Objective. Neoadjuvant radiotherapy (nRT) is an important treatment approach for rectal
cancer. The relationship, however, between nRT and postoperative complications is still …

Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with localized squamous cell carcinoma of the anal canal

SCR Oliveira, CMV Moniz, R Riechelmann… - Journal of …, 2016 - Springer
This was a phase II study of capecitabine in substitution of 5-fluorouracil (5-FU) in the
chemoradiotherapy regimen for patients with localized squamous cell carcinoma of the anal …